Seroprevalence of SARS-CoV-2 in Sweden, April 26 to May 9, 2021
- PMID: 35752708
- PMCID: PMC9233662
- DOI: 10.1038/s41598-022-15183-w
Seroprevalence of SARS-CoV-2 in Sweden, April 26 to May 9, 2021
Abstract
A national point seroprevalence study of SARS-CoV-2 was conducted in Sweden in April-May 2021. In total, 2860 individuals 3 to 90 years old from a probability-based web panel were included. Results showed that an estimated 32.6% of the population in Sweden had detectable levels of antibodies, and among non-vaccinated 20.1% had detectable levels of antibodies. We tested for differences in seroprevalence between age groups and by sex and estimated seroprevalence among previously infected participants by time since reporting.
© 2022. The Author(s).
Conflict of interest statement
JWB and MF are shareholders of Xerum AB that performed the serological analyses. All other authors declare that there is no conflict of interest.
References
-
- Public Health Agency of Sweden. Bekräftade fall i Sverige–daglig uppdatering. https://www.folkhalsomyndigheten.se/smittskydd-beredskap/utbrott/aktuell... (Accessed 12 Sept 2021).
-
- Public Health Agency of Sweden. Statistik för vaccination mot covid-19. https://www.folkhalsomyndigheten.se/smittskydd-beredskap/utbrott/aktuell... (Accesses 12 Sept 2021).
-
- Public Health Agency of Sweden. Hälsorapport–en webbpanel https://www.folkhalsomyndigheten.se/folkhalsorapportering-statistik/om-v... (Accessed 12 Sept 2021).
-
- Capitainer https://capitainer.se/kit/.
-
- Rosendal E, et al. Detection of asymptomatic SARS-CoV-2 exposed individuals by a sensitive S-based ELISA. medRxiv. 2020 doi: 10.1101/2020.06.02.20120477. - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
